Rituximab versus an alternative TNF inhibitor in patients with rheumatoid arthritis who failed to respond to a single previous TNF inhibitor: SWITCH-RA, a global, observational, comparative effectiveness study

P Emery; J E Gottenberg; A Rubbert-Roth; P Sarzi-Puttini; D Choquette; V M Martínez Taboada; L Barile-Fabris; R J Moots; A Ostor; A Andrianakos; E Gemmen; C Mpofu; C Chung; L Hinsch Gylvin; A Finckh

doi:10.1136/annrheumdis-2013-203993

Citation Tools

PDF

PDF +
Supplementary
Material

Clinical and epidemiological research

Extended report

Rituximab versus an alternative TNF inhibitor in patients with rheumatoid arthritis who failed to respond to a single previous TNF inhibitor: SWITCH-RA, a global, observational, comparative effectiveness study

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Cite this article as:: Emery P, Gottenberg JE, Rubbert-Roth A, et al

Rituximab versus an alternative TNF inhibitor in patients with rheumatoid arthritis who failed to respond to a single previous TNF inhibitor: SWITCH-RA, a global, observational, comparative effectiveness study

Annals of the Rheumatic Diseases 2015;74:979-984.

Log in using your username and password

Main menu

Log in using your username and password

You are here

Download to a citation manager

Read the full text or download the PDF:

Log in using your username and password